Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Market Cap $201.0M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
NZM | Ann: Update on director nominations and proposals | 23/07/25 | 19 | 3.1K | |||
|
|||||||
NZM | Ann: Resignation of Chief Financial Officer | 07/07/25 | 0 | 186 | |||
|
|||||||
NZM | Ann: Bowen Pan appointed Independent Director | 13/06/25 | 0 | 216 | |||
|
|||||||
NZM | Ann: Initial Disclosure Notice | 11/06/25 | 0 | 176 | |||
|
|||||||
NZM | Ann: Initial Disclosure Notice | 11/06/25 | 0 | 214 | |||
|
|||||||
NZM | Ann: Appointment of new Chair | 04/06/25 | 2 | 628 | |||
|
|||||||
NZM | Ann: Annual Shareholders' Meeting Results | 03/06/25 | 1 | 369 | |||
|
|||||||
NZM | Ann: ASM Presentation and Addresses | 03/06/25 | 0 | 282 | |||
|
See All Discussions
Timeline
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
View More |